US stock · US markets · public data

BMY

Bristol-Myers Squibb Co · Healthcare

Reference price$59.28Updated according to the public source
P/E13.06
P/B5.43
ROE46.60%
DY 12M4.23%
Net margin—
Net debt/equity—
Market capUS$ 121.1 B
Volume (shares)13,694,040
SectorHealthcare
Overview

About BMY

Demonstrações públicas consolidadas + SEC Company Facts

Bristol-Myers Squibb Co (BMY) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
09/22
03/23
06/23
09/23
03/24
06/24
09/24
03/25
06/25
09/25
03/26
06/26
Income in shown records$7.17
DY 12M4.23%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$0.63
Period ending 2026-03-31Dividendo declarado$0.63
Period ending 2025-09-30Dividendo declarado$0.62
Period ending 2025-06-30Dividendo declarado$0.62
Period ending 2025-03-31Dividendo declarado$0.62
Period ending 2024-09-30Dividendo declarado$0.60

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$45,006,000,000.00$48,300,000,000.00$48,194,000,000.00—
Gross Profit————
Net Income$8,025,000,000.00-$8,948,000,000.00$7,054,000,000.00—
EPS Diluted$3.86 / share-$4.41 / share$3.46 / share—

Balance sheet

Account2023202420252026
Total Assets$95,159,000,000.00$92,603,000,000.00$90,038,000,000.00—
Total Liabilities$65,674,000,000.00$76,215,000,000.00$71,533,000,000.00—
Total Equity$29,430,000,000.00$16,335,000,000.00$18,473,000,000.00—
Long-term Debt$36,653,000,000.00$47,603,000,000.00$42,850,000,000.00—
Current Debt$3,119,000,000.00$2,046,000,000.00$2,261,000,000.00—
Shares Outstanding2,098,775,978 shares2,022,193,411 shares2,029,312,023 shares2,036,473,705 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$13,860,000,000.00$15,190,000,000.00$14,156,000,000.00—
Capital Expenditures$1,209,000,000.00$1,248,000,000.00$1,311,000,000.00—
Dividends Paid$4,744,000,000.00$4,863,000,000.00$5,045,000,000.00—
Free Cash Flow$12,651,000,000.00$13,942,000,000.00$12,845,000,000.00—
FAQ

Frequently asked questions

What is the price of BMY?

The reference price available for BMY is $59.28.

What is the P/E of BMY?

The P/E ratio of BMY is 13.06. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of BMY?

The P/B of BMY is 5.43. This compares price with reported book value per share.

What is the ROE of BMY?

The ROE (Return on Equity) of BMY is 46.60%. This relates the reported net result to shareholders' equity.

What is the dividend yield of BMY?

The dividend yield of BMY is 4.23%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of BMY?

The market capitalization of BMY is US$ 121.1 B.

What sector is BMY in?

BMY operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.